In stroke, however, curative PHP.GFAP-IL-2 treatment after stroke induction did not reduce the resulting lesion size in either the dMCAO (Fig. 8b) or photothrombotic (Fig. 8c) models. This evidence concerns the gene IL2 and Stroke.